Pictet & Cie (Europe) Sa Arrowhead Pharmaceuticals, Inc. Transaction History

Pictet & Cie (Europe) Sa

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$27.21 - $39.48 $11,809 - $17,134	-434 Reduced 5.07%	8,125 $232,000
Q4 2023 Feb 09, 2024	SELL	$21.2 - $31.03 $6,911 - $10,115	-326 Reduced 3.67%	8,559 $261,000
Q3 2023 Nov 02, 2023	SELL	$26.2 - $36.08 $3,275 - $4,510	-125 Reduced 1.39%	8,885 $238,000
Q2 2023 Aug 08, 2023	SELL	$25.16 - $41.38 $12,026 - $19,779	-478 Reduced 5.04%	9,010 $321,000
Q4 2022 Feb 08, 2023	BUY	$28.0 - $40.56 $3,864 - $5,597	138 Added 1.48%	9,488 $0
Q3 2022 Nov 10, 2022	BUY	$29.63 - $48.31 $37,244 - $60,725	1,257 Added 15.53%	9,350 $309 Million
Q2 2022 Aug 05, 2022	SELL	$27.79 - $50.61 $3,056 - $5,567	-110 Reduced 1.34%	8,093 $285,000
Q1 2022 May 04, 2022	BUY	$39.62 - $69.97 $32,012 - $56,535	808 Added 10.93%	8,203 $377,000
Q4 2021 Feb 02, 2022	BUY	$58.09 - $82.51 $55,301 - $78,549	952 Added 14.78%	7,395 $490,000
Q3 2021 Nov 10, 2021	BUY	$58.38 - $84.96 $57,621 - $83,855	987 Added 18.09%	6,443 $402,000
Q2 2021 Aug 11, 2021	BUY	$62.15 - $90.32 $46,798 - $68,010	753 Added 16.01%	5,456 $452,000
Q1 2021 May 10, 2021	BUY	$61.35 - $90.47 $288,529 - $425,480	4,703 New	4,703 $312,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.